Therapeutic potential of CRF receptor antagonists: A gut-brain perspective

Expert Opinion on Investigational Drugs

Volumn 10, Issue 4, 2001, Pages 647-659

  Heinrichs, S C ^a   Tache Y ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Anxiety; Depression; Gastrointestinal motility; Irritable bowel syndrome; Post operative gastric ileus; Stress

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; 8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; ANTALARMIN; ANTISAUVAGINE 30; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; HORMONE ANTIBODY; LIGAND; NBI 30545; PEPTIDE; PYRROLOPYRIMIDINE DERIVATIVE; SAUVAGINE; SP 704; UNCLASSIFIED DRUG; UROCORTIN; UROTENSIN;

BRAIN; EXPOSURE; HUMAN; HYPOTHESIS; INTESTINE; MOLECULAR MIMICRY; MOUSE; NEUROBIOLOGY; NONHUMAN; PHYSIOLOGY; RAT; REVIEW; STRESS;

ANIMALS; ANTI-ANXIETY AGENTS; ANTI-INFLAMMATORY AGENTS; EATING DISORDERS; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0035066702     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.10.4.647     Document Type: Review

References (102)

1. Receptors for gut regulatory peptides
2. The behavioral neuroendocrinology of CRF, GRF, somatostatin and GnRH
3. Peptidergic regulation of gastrointestinal motility in rodents
4. Peptide hormone evolution: Functional heterogeneity within GnRH and CRF families
5. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists
6. Neurokinin receptor antagonists
7. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein and related peptides
8. Corticotropin-releasing factor, norepinephrine and stress
9. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors
10. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
11. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing Type 2 CRF receptors
12. Urocortin messenger ribonucleic acid: Tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids
13. Distribution and concentration of urocortin and effect of adrenalectomy on its content in rat hypothalamus
14. Urocortin mRNA is expressed in the enteric nervous system of the rat
15. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa
16. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone
17. Plasma CRH response to water immersion-restraint stress in rats bearing a hypothalamic knife cut
18. Activation of urocortin transport into brain by leptin
19. Characterization of corticotropin-releasing factor (CRF) receptor subtypes
20. Characterization of three corticotropin-releasing factor receptors in catfish: A novel third receptor is predominantly expressed in pituitary and urophysis
21. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders
22. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
23. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF 2γ receptor
24. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat
25. Characterisation using microphysiometry of CRF receptor pharmacology
26. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges
27. Ligand requirements of the human corticotropin releasing factor-binding protein
28. Corticotropin releasing factor (CRF) receptor modulators: Progress and opportunities for new therapeutic agents
29. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta-selective anti sauvagine-30
30. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
31. Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP) and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain
32. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser(7) substitutions
33. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors
34. Corticotropin-releasing factor antagonists, binding-protein and receptors: Implications for central nervous system disorders
35. Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
36. Corticotropin-releasing hormone receptor antagonists: Framework design and synthesis guided by ligand conformational studies
37. 2α receptors
38. Recent advances with the CRF1 receptor: Design of small molecule inhibitors, receptor subtypes and clinical indications
39. Non-peptide corticotropin-releasing hormone antagonists: Syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines
40. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
41. Corticotropin-releasing hormone and animal models of anxiety: Gene-environment interactions
42. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents
43. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine and autonomic responses to stress in primates
44. Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
45. Corticotropin-releasing hormone1 receptors mediate consensus interferon-α YM643-induced depression-like behavior in mice
46. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal
47. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence
48. CP-154,526, a selective, non peptide antagonist of the corticotropin-releasing Factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats
49. Pathways to relapse: The neurobiology of drug- and stress-induced relapse to drug-taking
50. Corticotropin-releasing hormone: Possible role in eating disorders
51. Stress coping strategy in Japanese patients with eating disorders: Relationship with bulimic and impulsive behaviors
52. Abnormal gastric emptying in primary anorexia nervosa
53. Delayed gastric emptying in bulimic patients
54. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
55. Corticotropin-releasing factor and the brain-gut motor response to stress
56. Corticotropin-releasing factor receptor Type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
57. Body dissatisfaction, bulimia and depression among women: The mediating role of drive for thinness
58. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve Type 1 receptor in rats
59. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats
60. Anxiety and depression: A common feature of health care seeking patients with irritable bowel syndrome and food allergy
61. Stress-induced visceral hypersensitivity to rectal distension in rats: Role of CRF and mast cells
62. Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats
63. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: Protective role of brain CRF
64. Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor
65. Corticotropin-releasing hormone and inflammation
66. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease
67. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
68. Local secretion of corticotropin-releasing factor receptor expression in the human colonic mucosa
69. Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats
70. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis
71. Cyclic vomiting syndrome: The corticotropin-releasing-factor hypothesis
72. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat
73. Acute stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells
74. Peripheral CRF stimulates colonic propulsion and inhibits gastric emptying in mice: Differential role of CRF receptor subtype 1 and 2
75. 125I-Antisauvagine-30: A novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor Type 2 receptors
76. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1
77. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
78. Stress-axis, coping and dementia: Gene-manipulation studies
79. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
80. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF
81. Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats
82. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: The role of CRF2 receptors
83. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to opiate dependence in rats
84. Peripheral administration of a corticotropin-releasing factor antagonist increases the vocalizing and locomotor activity of isolated guinea pig pups
85. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice
86. Peripheral administration of CRF and urocortin: Effects on food intake and the HPA axis in marsupial sminthopsis crassicaudata
87. CRF receptor types involved in peripheral urocortin-induced inhibition of food intake and gastric emptying in mice
88. Effects of newly developed CRF receptor antagonist, astressin B on peripheral CRF-induced gastric relaxation
89. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats
90. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
91. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
92. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
93. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
94. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome
95. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery
96. Corticotropin-releasing factor receptor 1 in mouse spleen: Expression after immune stimulation and identification of receptor-bearing cells
97. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence
98. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
99. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
100. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: In vivo evidence using a novel, selective, non-peptide CRF receptor antagonist
101. A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep